Q4 2024 Management View CEO Randall Stuewe highlighted that Darling Ingredients delivered its strongest quarter of 2024, reducing financial leverage to 3.68x and paying down $353 million in debt. The ...

Q4 2024 Management View CEO David Ricks highlighted a 45% revenue growth in Q4, with significant contributions from Mounjaro and Zepbound. He emphasized ongoing expansion in manufacturing to meet ...

Q4 2024 Earnings Call Feb 06, 2025, 6:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants ...

Yum China Holdings, Inc. (NYSE:YUMC) shares are trading higher on Thursday after the fourth-quarter FY24 earnings result. The ...

Colliers took in $1.5B in revenue in the fourth quarter, more than half of which came from recurring revenue, as sales and ...

Baron Growth Fund® (the Fund) gained 5.02% (Institutional Shares) for the year ended December 31, 2024. Read more here.

ConocoPhillips (NYSE:COP) shares are trading higher after the company released fourth-quarter results. Here’s a breakdown of ...

Strategy (formerly MicroStrategy) reported a $1.016 billion Q4 2024 loss, largely due to Bitcoin impairment charges.

Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of non-incretin products, which grew sales 20% in the fourth quarter, should “help ...

Philip Morris International exceeded earnings expectations for Q4, propelled by its expanding smoke-free product lineup.

Eli Lilly reported mixed fourth-quarter results on Thursday, surpassing earnings expectations but falling short of sales projections, even as demand for its flagship weight loss drug Zepbound and ...

Eli Lilly ( LLY 3.89%) stock inched 2.5% higher through 9:50 a.m. ET Thursday after beating on the top and bottom lines in ...